Telaprevir combination therapy in treatment-naive and experienced patients co-infected with HCV and HIV

被引：0

作者：

Montes, Marisa ^{[1
]}

Nelson, Mark ^{[2
]}

Girard, Marie ^{[3
]}

Sasadeusz, Joe ^{[4
]}

Horban, Andrzej ^{[5
]}

Grinsztejn, Beatriz ^{[6
]}

Zakharova, Natalia ^{[7
]}

Falconer, Karolin ^{[8
]}

Dierynck, Inge ^{[9
]}

Luo, Donghan ^{[10
]}

Ma, Yi-Wen ^{[10
]}

Witek, James ^{[10
]}

机构：

[1] Hosp La Paz, Madrid, Spain

[2] Chelsea & Westminster Hosp, London, England

[3] Hop St Antoine, Paris, France

[4] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia

[5] Hosp Infect Dis, Warsaw, Poland

[6] Inst Pesquisa Clin Evandro Chagas, STD AIDS Clin Res Lab, Rio De Janeiro, Brazil

[7] St Petersburg AIDS Ctr, St Petersburg, Russia

[8] Karolinska Univ Hosp, Stockholm, Sweden

[9] Janssen Infect Dis BVBA, Beerse, Belgium

[10] Janssen Res & Dev LLC, Titusville, NJ USA

来源：

HEPATOLOGY | 2013年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：225A / 226A

页数：2

共 50 条

[31] Survival in HCV/HIV co-infected patients.
Hassanein, TI
Aronson, N
Oliver, DL
Barber, E
Hilsabeck, RC
Chatfield, E
Stewart, M
Mathews, C
HEPATOLOGY, 2001, 34 (04) : 232A - 232A
[32] Sofosbuvir and ledipasvir for HIV/HCV co-infected patients
Rosenthal, Elana S.
Kottilil, Shyam
Polis, Michael A.
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 743 - 749
[33] HLA FOOTPRINTS IN HIV/HCV CO-INFECTED PATIENTS
Dold, L.
Althausen, E.
Schwarze-Zander, C.
Boesecke, C.
Wasmuth, J. -C.
Strassburg, C. P.
Rockstroh, J. K.
Spengler, U.
JOURNAL OF HEPATOLOGY, 2013, 58 : S149 - S149
[34] Liver fibrosis in HIV/HCV co-infected patients
Cajoto, IV
Airas, EL
Martínez, AP
Guirao, AA
MEDICINA CLINICA, 2005, 124 (12): : 477 - 477
[35] Metabolic Syndrome in HIV/HCV Co-infected Patients
Lauren F. Collins
Ruth O. Adekunle
Emily J. Cartwright
Current Treatment Options in Infectious Diseases, 2019, 11 : 351 - 371
[36] Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naive and experienced HIV co-infected Ghanaian patients
Archampong, Timothy N. A.
Lartey, Margaret
Sagoe, Kwamena W.
Obo-Akwa, Adjoa
Kenu, Ernest
Gillani, Fizza S.
Yang, Hongmei
Boamah, Isaac
Flanigan, Timothy
Kwara, Awewura
BMC INFECTIOUS DISEASES, 2016, 16
[37] Hospital epidemiology of patients co-infected by HIV and HCV
Thélot, B
Pialoux, G
Delhommeau, A
Piroth, L
Salmon-Céron, D
MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (10): : 605 - 608
[38] Metabolic Syndrome in HIV/HCV Co-infected Patients
Collins, Lauren F.
Adekunle, Ruth O.
Cartwright, Emily J.
CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2019, 11 (04) : 351 - 371
[39] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
Bollepalli, S
Mahthieson, K
Post, J
Hillier, A
Nadir, A
HEPATOLOGY, 2005, 42 (04) : 423A - 423A
[40] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
Rockstroh, Juergen K.
LIVER INTERNATIONAL, 2015, 35 : 51 - 55

← 1 2 3 4 5 →